$84 Million is the total value of Vida Ventures Advisors, LLC's 7 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plcordinary shares | $31,297,271 | +23.0% | 3,931,818 | 0.0% | 37.26% | -5.4% | |
| DYN | Sell | Dyne Therapeutics, Inc. | $27,594,667 | +38.7% | 2,074,787 | -6.5% | 32.85% | +6.7% |
| LianBioordinary shares | $10,200,916 | +200.0% | 2,282,084 | 0.0% | 12.14% | +130.7% | ||
| ALLO | Allogene Therapeutics, Inc. | $5,772,103 | +1.3% | 1,798,163 | 0.0% | 6.87% | -22.1% | |
| KNTE | Kinnate Biopharma, Inc. | $5,232,420 | +69.3% | 2,207,772 | 0.0% | 6.23% | +30.2% | |
| KRON | Kronos Bio, Inc. | $3,456,643 | -3.8% | 2,765,314 | 0.0% | 4.12% | -26.0% | |
| IKNA | Ikena Oncology, Inc. | $443,628 | -54.5% | 225,192 | 0.0% | 0.53% | -65.0% | |
| PRAX | Exit | Praxis Precision Medicines, Inc. | $0 | – | -1,469,665 | -100.0% | -3.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-01-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Dyne Therapeutics, Inc. | 14 | Q4 2023 | 37.4% |
| Allogene Therapeutics, Inc. | 14 | Q4 2023 | 42.5% |
| Kinnate Biopharma, Inc. | 13 | Q4 2023 | 29.3% |
| Kronos Bio, Inc. | 13 | Q4 2023 | 20.4% |
| Praxis Precision Medicines, Inc. | 12 | Q3 2023 | 33.2% |
| Centessa Pharmaceuticals plc | 11 | Q4 2023 | 39.4% |
| LianBio | 9 | Q4 2023 | 12.1% |
| Homology Medicines, Inc. | 9 | Q3 2022 | 5.2% |
| Oyster Pt Pharma Inc | 5 | Q3 2021 | 10.3% |
| Assembly Biosciences, Inc. | 4 | Q2 2021 | 4.6% |
View Vida Ventures Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-01-05 |
| 13F-HR | 2023-10-03 |
| 13F-HR | 2023-07-19 |
| 13F-HR | 2023-04-13 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-10-05 |
| 13F-HR | 2022-07-15 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-10 |
View Vida Ventures Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.